You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 108 No. 4, Oct 1961 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (14)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Severe Herpes Zoster During Corticosteroid Therapy

Report of a Severe Attack in a Patient with Rheumatoid Arthritis

WILLIAM F. ECKHARDT, JR., M.D.; GEORGE W. HEBARD, M.D.

Arch Intern Med. 1961;108(4):594-598.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The recent reports of Weller and coworkers have clearly identified the causative viral agent of herpes zoster infection in man, and have emphasized the impressive evidence that a single virus is probably responsible for both varicella and herpes zoster infections.1,2

Advances in the therapy of zoster infections have not kept pace with these advances in our fundamental knowledge of the virus' properties. Epstein and Allington have reported the results of treating 251 patients with herpes zoster infections with one or combinations of the following agents: autohemotherapy, antibiotics, thiamine, posterior pituitary hormone injection (Pituitrin), x-ray, analgesics, corticosteroids, infrared lamp, vasodilators, sulfonamides, Protamide, and immune globulin.3 Regardless of the mode of therapy, the average course of the disease was found to be 2 to 3 weeks. Single or combination therapy with any of these agents failed to shorten the natural course of the disease. Their results clearly point out the . . . [Full Text PDF of this Article]


Author Affiliations

NEW CANAAN, CONN.


Footnotes

Submitted for publication July 26, 1960.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1961 American Medical Association. All Rights Reserved.